Daniel Feinstein
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Intensive Care Unit Cognitive Disorders 2
-
- Sepsis Diagnosis and Treatment 5
- Co-authors
- Aseem Kumar (4 shared papers)Anand Kumar (4 shared papers)Joseph E. Parrillo (4 shared papers)Sergio L Zanotti (3 shared papers)Bruce Light (2 shared papers)Kenneth E. Wood (2 shared papers)Leo Taiberg (1 shared paper)DANIEL E. ROBERTS (1 shared paper)
- Journals
- Critical Care Medicine (2 papers)New England Journal of Medicine (1 paper)The Lancet Respiratory Medicine (1 paper)Critical Care (1 paper)Expert Opinion on Investigational Drugs (1 paper)
- Partner nations
- United StatesCanadaSaudi Arabia
In The Last Decade
Daniel Feinstein
8 papers receiving 5.5k citations
Daniel Feinstein's Hit Papers
Peers
Comparison fields: 5 of 119
- Applied Microbiology and Biotechnology 481
- Clinical Biochemistry 693
- Critical Care and Intensive Care Medicine 551
- Epidemiology 2.7k
- Molecular Medicine 344
Countries citing papers authored by Daniel Feinstein
This map shows the geographic impact of Daniel Feinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Feinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Feinstein more than expected).
Fields of papers citing papers by Daniel Feinstein
This network shows the impact of papers produced by Daniel Feinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Feinstein. The network helps show where Daniel Feinstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Feinstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* Hit paper breakdown → | 2006 | 4718 |
| 2 | Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness Hit paper breakdown → | 2018 | 412 |
| 3 | 2010 | 350 | |
| 4 | 2013 | 165 | |
| 5 | 2012 | 124 | |
| 6 | 2002 | 44 | |
| 7 | 2024 | 17 | |
| 8 | 2014 | 5 |
About Daniel Feinstein
Daniel Feinstein is a scholar working on Critical Care and Intensive Care Medicine, Epidemiology, Endocrinology, Diabetes and Metabolism, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 8 papers that have together received 5.8k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (5 papers), Intensive Care Unit Cognitive Disorders (2 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (481 citations), Clinical Biochemistry (693 citations), Critical Care and Intensive Care Medicine (551 citations), Epidemiology (2.7k citations) and Molecular Medicine (344 citations). Daniel Feinstein has collaborated with scholars based in United States, Canada and Saudi Arabia. Frequent co-authors include Aseem Kumar, Anand Kumar, Joseph E. Parrillo, Sergio L Zanotti, Bruce Light, Kenneth E. Wood, Leo Taiberg, DANIEL E. ROBERTS, Mary Cheang and Satendra Sharma. Their work appears in journals such as Critical Care Medicine, New England Journal of Medicine, The Lancet Respiratory Medicine, Critical Care and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.